SMCZ SMCX: Betting Against or All-In on SMCI in AI Servers
Two 2x levered SMCI ETFs are delivering divergent outcomes in mid-2026 as AI server demand fluctuates and governance ...
Using Index Funds In Retirement Portfolios discusses straightforward methods to blend broad-market index funds into retirement allocations.
18,590 articlesTwo 2x levered SMCI ETFs are delivering divergent outcomes in mid-2026 as AI server demand fluctuates and governance ...
Investors confront a tough choice: buy Nvidia for big gains or rely on NVDY's weekly income stream, which comes with ...
Fermentation is moving from kitchen experiments to a mainstream personal-finance story, even as questions linger abou...
Authorities say 72 tigers died thai zoos in Chiang Mai from canine distemper, not bird flu, easing human health fears...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Latin American ETFs EWZ and EWW are leading a regional rally in 2026, powered by stronger commodity markets and a shi...
DeepSeek just secured its first outside investment from a state-backed fund, marking a turning point in China’s AI fu...
As AI expands from novelty to durable demand, investors wonder if the AI trade is entering its second wave. This arti...
Treasury's crypto policy lead is pushing for CLARITY Act passage by summer 2026 and signaling a cautious, deliberatel...
Standard Chartered unveils a bold UNI price forecast for 2030, arguing tokenized assets will push DeFi liquidity to t...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...